Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 12, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • Merck

Tag: Merck

  • BiotechToday
  • World

Shionogi is in a race against Pfizer and Merck

BioTech Today August 4, 2021August 4, 2021 2

Sneha Singhal, Jaypee Institute of information technology, Noida Pfizer Inc. and Merck & Co. in the race to find treatments for Covid-19 have joined a Japanese company in starting human trials for the first once-daily pill. Shionogi and Co., of Osaka, claimed that its pill would neutralize the Coronavirus in five days or less. The […]

Read More
  • BiotechToday
  • World

The current Ebola Epidemic comes to an end

BioTech Today June 21, 2021June 20, 2021 2

Soumya Shraddhya Paul, Amity University Noida On Saturday, WHO official Alfred Ki-Zerbo declared the end of the current Ebola epidemic. After Guinea defeated the second Ebola outbreak that erupted in the West African states on February 14th, 2021 which infected around 16 people and claimed the life of 12, the second wave is reported to […]

Read More
  • BiotechToday
  • World

Molnupiravir: The real game-changer for COVID-19?

bioxone March 20, 2021March 20, 2021 3

Shagufta Hasan, Amity University Kolkata  The world has had hard knocks with COVID-19 vaccines but no drug seems to give full coverage against the virus, but now, it may hope for good news. A new drug, Molnupiravir, has been developed by Merck & Co. Inc in association with Ridgeback Biotherapeutics, a biotechnology company, focused on […]

Read More
  • Job and Internship
  • Signaling Pathway

Merck Pharma Regulatory Advocacy Job For Life Science | Apply Online

bioxone October 28, 2020October 27, 2020

-Shristi Sharma, Team bioXone Merck Life Sciences Vacancy For MSc/PhD – Apply Online. MSc/PhD Life Science/candidates apply online for Expert, Pharm Regulatory Advocacy position at Merck. Interested and eligible candidates check all the below: Job Title: Expert, Pharm Regulatory Advocacy Job Requisition ID: 208118 Location: Mumbai Your role: The candidate will be a key regulatory […]

Read More

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy